Research studies that will investigate perinatal depression in women and possible new treatments for it will be led by Kristina Deligiannidis, MD, of the Feinstein Institutes' Institute of Behavioral Science, Glen Oaks, New York.
People with major depressive disorder, bipolar disorder, or schizophrenia appear to metabolize tryptophan in the brain differently than people without mental health disorders, according to a published study.
Almost half of young adults in the United States show at least moderate symptoms of depression, according to a nationwide survey published online by the COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States.
Social anxiety symptoms in children exposed to maternal major depressive disorder (MDD) increased children’s risk of developing depressive symptoms over time, according to a study published in the Journal of Adolescence.
Psych Congress cochair Charles Raison, MD, will give a virtual keynote speech August 20, 2020, for the University of Louisville Depression Center’s annual benefit. The event is free and open to the public.
AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.